Steve Miller - 13 Dec 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
13 Dec 2024
Net transactions value
+$942,350
Form type
4
Filing time
17 Dec 2024, 17:24:40 UTC
Previous filing
11 Dec 2024
Next filing
31 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $942,350 +235,000 +34% $4.01 921,996 13 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -235,000 -13% $0.000000 1,552,176 13 Dec 2024 Common Stock 235,000 $4.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vested in three annual tranches beginning on January 2, 2019.